Published in J Immunol Methods on January 01, 2004
Intrathecal synthesis of oligoclonal IgM against myelin lipids predicts an aggressive disease course in MS. J Clin Invest (2005) 1.41
Brain atrophy and lesion load are related to CSF lipid-specific IgM oligoclonal bands in clinically isolated syndromes. Neuroradiology (2011) 0.84
Glial and neuronal antibodies in patients with idiopathic intracranial hypertension. Neurol Sci (2017) 0.75
Guidelines for the treatment of acute ischaemic stroke. Neurologia (2011) 2.05
An evaluation of different saliva collection methods for detection of antibodies against hepatitis C virus (anti-HCV). J Oral Pathol Med (2012) 1.48
Clinically isolated syndromes: a new oligoclonal band test accurately predicts conversion to MS. Neurology (2006) 1.46
Off-label intravenous thrombolysis in acute stroke. Eur J Neurol (2011) 1.44
Intestinal intraepithelial lymphocytes contain a CD3- CD7+ subset expressing natural killer markers and a singular pattern of adhesion molecules. Scand J Immunol (2000) 1.11
Disorders of regulatory T cells in patients with selective IgA deficiency and its relationship to associated autoimmune phenomena. Clin Exp Immunol (1982) 1.09
Hepatitis A virus in environmental water samples from the Amazon Basin. Water Res (2007) 1.08
Interleukin-6 dimers produced by endothelial cells inhibit apoptosis of B-chronic lymphocytic leukemia cells. Blood (2001) 1.02
HLA antigens in a sample of the Spanish population: common features among Spaniards, Basques, and Sardinians. Hum Genet (1981) 0.97
Familial C1q deficiency associated with renal and cutaneous disease. Clin Exp Immunol (1981) 0.97
Flow cytometry description of a novel CD3-/CD7+ intraepithelial lymphocyte subset in human duodenal biopsies: potential diagnostic value in coeliac disease. Cytometry (1998) 0.96
In-hospital stroke: a multi-centre prospective registry. Eur J Neurol (2011) 0.96
Lithium-induced headache. Headache (1989) 0.95
Intrathecal IgM synthesis in neurologic diseases: relationship with disability in MS. Neurology (2002) 0.95
[Cerebral venous thrombosis: when etiology makes the difference]. Neurologia (2009) 0.94
Anti-transglutaminase IgA ELISA: clinical potential and drawbacks in celiac disease diagnosis. Scand J Gastroenterol (2001) 0.92
[Recommendations for using and interpreting magnetic resonance imaging in multiple sclerosis]. Neurologia (2010) 0.91
Intrathecal IgM synthesis predicts the onset of new relapses and a worse disease course in MS. Neurology (2002) 0.91
Detection of soluble class I molecules (non HLA-A or HLA-B) in serum, spleen membranes and lymphocytes in culture. Eur J Immunol (1989) 0.90
Use of the ELISA to detect and quantify histocompatibility antigens and their subunits. J Immunol Methods (1983) 0.90
Hepatocyte damage induced by lymphocytes from patients with chronic liver diseases, as detected by LDH release. Clin Exp Immunol (1978) 0.90
Soluble HLA class I antigen secretion by normal lymphocytes: relationship with cell activation and effect of interferon-gamma. Clin Exp Immunol (1990) 0.90
Immunological findings in immunoblastic lymphadenopathy. A detailed case study. Clin Exp Immunol (1977) 0.88
Guidelines for the preventive treatment of ischaemic stroke and TIA (II). Recommendations according to aetiological sub-type. Neurologia (2011) 0.88
Simultaneous detection of hepatitis C virus antigen and antibodies in dried blood spots. J Clin Virol (2013) 0.88
Diffuse plasma cell infiltration of the small intestine with malabsorption associated to IgA monoclonal gammapathy. Cancer (1974) 0.88
A sensitive and reproducible method for the detection of oligoclonal IgM bands. J Immunol Methods (2001) 0.87
B cell hyperactivity and abnormalities in T cell markers and immunoregulatory function in a patient with nucleoside phosphorylase deficiency. Clin Exp Immunol (1982) 0.87
Response to interferon in multiple sclerosis is related to lipid-specific oligoclonal IgM bands. Mult Scler (2010) 0.86
Clinical practice guidelines in intracerebral haemorrhage. Neurologia (2011) 0.86
Multiple sclerosis patients with anti-lipid oligoclonal IgM show early favourable response to immunomodulatory treatment. Eur J Neurol (2009) 0.86
Increased soluble serum HLA class I antigens in patients with lymphoma. Hum Immunol (1997) 0.86
Vaccination against hepatitis B with 4-double doses increases response rates and antibodies titers in HIV-infected adults. Vaccine (2012) 0.85
Slow allotypic variants of the NAT2 gene and susceptibility to early-onset Parkinson's disease. Neurology (1998) 0.85
Lumphocytotoxins in leprosy. Int J Lepr Other Mycobact Dis (1976) 0.85
Abnormal B cell function in haemophiliacs and their relationship with factor concentrates administration. Clin Exp Immunol (1985) 0.85
Efficacy of intravenous thrombolysis according to stroke subtypes: the Madrid Stroke Network data. Eur J Neurol (2012) 0.85
Lipid-specific immunoglobulin M in CSF predicts adverse long-term outcome in multiple sclerosis. Mult Scler (2008) 0.85
Botulism with sensory symptoms: a second case. J Neurol Neurosurg Psychiatry (1991) 0.85
The risk of relapse after a clinically isolated syndrome is related to the pattern of oligoclonal bands. J Neuroimmunol (2010) 0.84
Interferon beta-1b treatment in patients with relapsing--remitting multiple sclerosis under a standardized protocol in Spain. Acta Neurol Scand (2000) 0.84
Increased levels of IL-15 mRNA in relapsing--remitting multiple sclerosis attacks. J Neuroimmunol (2002) 0.84
Natural killer cell subsets in cerebrospinal fluid of patients with multiple sclerosis. Clin Exp Immunol (2015) 0.83
Disorders of regulatory T cell function in patients with the Wiskott-Aldrich syndrome. Clin Exp Immunol (1984) 0.83
HLA factors in non-insulin-dependent diabetes mellitus. N Engl J Med (1980) 0.83
Functional assessment of T and B lymphocytes in patients with selective IgM deficiency. Clin Exp Immunol (1982) 0.82
Studies on the quaternary structure of class I major histocompatibility complex antigens. Effect of different agents on the interaction between subunits. J Biol Chem (1986) 0.82
The costs of stroke in Spain by aetiology: the CONOCES study protocol. Neurologia (2012) 0.82
[Cerebellar syndrome and myoclonus in a patient with adenocarcinoma of the colon]. Rev Neurol (2000) 0.81
Fluorocytometric analysis of induced sputum cells in an asthmatic population. J Investig Allergol Clin Immunol (2004) 0.81
Reverse enzyme immunoassay for the determination of Dermatophagoides pteronyssinus IgE antibodies. Int Arch Allergy Appl Immunol (1983) 0.81
Cranial computed tomography in pediatric migraine. Pediatr Radiol (1984) 0.81
Axonal damage induced by cerebrospinal fluid from patients with relapsing-remitting multiple sclerosis. J Neuroimmunol (2000) 0.81
Purification and properties of membrane and cytosolic phosphatidylinositol-specific phospholipases C from human spleen. J Biol Chem (1991) 0.81
Detection of hepatitis A virus RNA in serum during the window period of infection. J Clin Virol (2004) 0.80
Intrathecal synthesis of soluble class I antigens in multiple sclerosis. J Neuroimmunol (1992) 0.80
Induction of apoptosis by cerebrospinal fluid from patients with primary-progressive multiple sclerosis in cultured neurons. Neurosci Lett (1998) 0.80
Clinical management guidelines for subarachnoid haemorrhage. Diagnosis and treatment. Neurologia (2012) 0.80
Caspase inhibitors protect against neuronal apoptosis induced by cerebrospinal fluid from multiple sclerosis patients. J Neuroimmunol (2003) 0.80
Increased levels of plasma von Willebrand factor in migraine crisis. Acta Neurol Scand (1995) 0.80
Lack of crossreaction with Bet v 1 in patients sensitized to Dau c 1, a carrot allergen. Ann Allergy Asthma Immunol (1999) 0.80
[Mediterranean lymphoma: study of 10 cases, 3 of them associated to paraproteinemia]. Rev Clin Esp (1978) 0.80
Soluble class 1 antigens (sHLA) in CSF and serum of patients with HIV infection. Acta Neurol Scand (1990) 0.80
Limitations of anti-guinea pig liver transglutaminase IgA in screening of celiac disease. Gastroenterology (2001) 0.80
The not so benign syndrome of transient headache with neurologic deficits and CSF lymphocytosis. Neurology (1998) 0.79
Bf polymorphism and its relationship with HLA antigens in a sample of the Spanish Population: high BfF1 frequencies. Tissue Antigens (1981) 0.79
Dried blood spot samples: optimization of commercial EIAs for hepatitis C antibody detection and stability under different storage conditions. J Med Virol (2012) 0.79
HL-A antigens in leprosy. Tissue Antigens (1974) 0.79
Utility of oligoclonal IgG band detection for MS diagnosis in daily clinical practice. J Immunol Methods (2011) 0.79
Modulatory effect of hydrocortisone on T-lymphocyte regulatory activity in pokeweed mitogen-driven Ig production. Clin Immunol Immunopathol (1983) 0.79
Lipid composition of platelets in patients suffering from migraine without aura. Headache (1996) 0.78
Identification of the major HHV-6 antigen recognized by cerebrospinal fluid IgG in multiple sclerosis. Eur J Neurol (2014) 0.78
Guidelines for the preventive treatment of ischaemic stroke and TIA (I). Update on risk factors and life style. Neurologia (2011) 0.78
Ipsilateral mydriasis in focal occipitotemporal seizures. J Neurol Neurosurg Psychiatry (1997) 0.78
Tamoxifen: a new risk factor for cerebral sinus thrombosis. Neurology (2004) 0.78
Frequency of CYP2D6 allelic variants in multiple sclerosis. Acta Neurol Scand (1995) 0.78
Description of an enzyme-linked immunosorbent assay for the detection of protein tyrosine kinase. Anal Biochem (1991) 0.78
[Solitary costal plasmacytoma: a rare cause of subacute demyelinating polyradiculoneuropathy]. Neurologia (2006) 0.78